Answers are grounded in this paper and cite their sources.
We propose a slight modification of replacement randomization by imposing an imbalance criterion within a restricted range of patient entry numbers. The bound on imbalance is stated most simply in terms of the maximum allowable difference in treatment assignments at the end of the trial. For clinical trials in which two therapies are compared, we study, by means of computer simulations, the dependence of both selection bias and the mean number of randomization list replacements on the parameters defining the procedure.
No takes yet. Share an insight, caveat, or question.
Ulrich Abel (1987) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: